Endurant Capital Management LP - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 62 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,139,000
+94.7%
90,041
+406.5%
0.26%
+69.3%
Q1 2021$585,00017,7770.15%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$23,927,0008.46%
Nan Fung Group Holdings Ltd 1,166,952$14,762,0004.72%
Novo Holdings A/S 4,503,991$56,975,0002.95%
Vivo Capital, LLC 3,871,291$48,972,0002.20%
Sofinnova Investments, Inc. 2,754,437$34,844,0002.06%
Samsara BioCapital, LLC 737,459$9,329,0001.46%
Ally Bridge Group (NY) LLC 257,267$3,254,0000.96%
Board of Trustees of The Leland Stanford Junior University 719,546$9,102,0000.68%
Rock Springs Capital Management LP 1,649,248$20,863,0000.44%
RA Capital Management 2,378,325$30,086,0000.42%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders